Skip to main content
Signal8
HOLMES EDWARD W profile photo

Edward W. Holmes

CIK: 0001197099

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Arcturus Therapeutics Holdings Inc. logo
ARCT

Arcturus Therapeutics Holdings Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Arcturus Therapeutics Holdings Inc. logo
    ARCT

    Arcturus Therapeutics Holdings Inc.

    Jun 5, 2026
    Award(A)

    Stock option (right to buy)

    Direct
    15K shares-
  • Arcturus Therapeutics Holdings Inc. logo
    ARCT

    Arcturus Therapeutics Holdings Inc.

    Jun 9, 2025
    Award(A)

    Stock option (right to buy)

    Direct
    15K shares-

1-2 of 2

About HOLMES EDWARD W

HOLMES EDWARD W (SEC CIK 0001197099) files insider reports with the SEC as Director of Arcturus Therapeutics Holdings Inc. (ARCT).

Signal8 holds 2 ownership filings by HOLMES EDWARD W, all Form 4s, filed between Jun 11, 2025 and Jun 15, 2026. Those filings report 2 transactions, from Jun 9, 2025 to Jun 5, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on HOLMES EDWARD W's filings is in SAN DIEGO, CA.

Recent filings by HOLMES EDWARD W

  • Jun 5, 2026: Grant or award of ARCT derivative securities (Form 4, code A).
  • Jun 9, 2025: Grant or award of ARCT derivative securities (Form 4, code A).

Other insiders filing for Arcturus Therapeutics Holdings Inc. (ARCT)

How to read Form 4 transaction codes